915810-67-2
915810-67-2 structure
- Name: Caplacizumab
- Chemical Name: Caplacizumab
- CAS Number: 915810-67-2
- Molecular Formula:
- Molecular Weight:
- Catalog: Research Areas Cancer
- Create Date: 2022-10-12 15:45:06
- Modify Date: 2023-10-20 22:37:58
-
Caplacizumab (Cablivi) is a humanized anti-von Willebrand factor (vWF) nanobody. Caplacizumab inhibits the vWF-mediated platelet adhesion and prevents further microthrombi formation. Caplacizumab can be used for the research of thrombotic thrombocytopenic purpura (TTP)[1].
| Name | Caplacizumab |
|---|
| Description | Caplacizumab (Cablivi) is a humanized anti-von Willebrand factor (vWF) nanobody. Caplacizumab inhibits the vWF-mediated platelet adhesion and prevents further microthrombi formation. Caplacizumab can be used for the research of thrombotic thrombocytopenic purpura (TTP)[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |